Analysts at Barclays initiate coverage of Teva Pharmaceutical Industries Ltd TEVA with an “overweight” rating. The target price for TEVA is set to $32.
TEVA shares rose 0.59% to close at $49.27 yesterday.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in